Utility of biochemical screening in the context of evaluating patients with a presumptive diagnosis of osteoporosis

Clinical Rheumatology

Volumn 26, Issue 3, 2007, Pages 362-365

  Rajeswaran, Crajesh ^a   Spencer, J ^a   Barth, J H ^a   Orme, S M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Biochemical screening; Diagnosis; Osteoporosis

Indexed keywords

BENCE JONES PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; LIPID; PLASMA PROTEIN;

ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; BONE DENSITY; BONE MINERAL; CALCIUM HOMEOSTASIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROPHORESIS; FEMALE; FEMUR NECK; HUMAN; HYPOTHYROIDISM; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATIENT REFERRAL; PLASMA VISCOSITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; SPINE; THYROID DISEASE; THYROID FUNCTION TEST; THYROTOXICOSIS;

BONE DENSITY; CHOLESTEROL; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MULTIPHASIC SCREENING; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROTOXICOSIS;

EID: 33947660005     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0320-4     Document Type: Article

References (16)

1. World Health Organisation (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO technical report series no. 843. World Health Organisation, Geneva
2. Caplan GA, Scane AC, Francis RM (1994) Pathogenesis of vertebral crush fractures in women. J R Soc Med 87:200-202
3. Scane AC, Sutcliffe AM, Francis RM (1993) Osteoporosis in men. Baillieres Clin Rheumatol 7:589-601
4. Crandall C (2003) Laboratory workup for osteoporosis. Which tests are most cost-effective? Postgrad Med 114(3):35-44
5. Ikkos D-G, Katsichtis P, Ntalles K, Velentzas C (1971) Osteoporosis in thyrotoxicosis. Lancet 2(7734):1159
6. Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A (1991) Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 72:1189-1194
7. Stall Gm, Harris S, Skoll LJ, Dawson-Hughes B (1990) Accelerated bone loss in hypothyroid patients over treated with l -thyroxine. Ann Intern Med 113:265-269
8. Cummings SR, Tao JL, Browner WS; the study f Osteoporotic fracture research group (1992) Hyperthyroidism increases the risk of hip fracture: A prospective study. J Bone Miner Res 7(Supplement 1):S121
9. Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP (2004) Long-term effects of serum cholesterol on bone mineral density in women and men: The Framingham Osteoporosis Study. Bone 34(3):557-561
10. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32(1):8-14
11. Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L (2004) Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19(5):737-744
12. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HN, Dunn WL, calvo MS, Harris TB, Heyse SP (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761-1768
13. Orwoll E (1998) Osteoporosis in men. Endocrol Metab Clin N Am 27:349-368
14. Johnson BE, Lucasey B, Robinson RG, Lukert BP (1989) Contributing diagnoses in osteoporosis: The value of a complete medical evaluation. Arch Intern Med 149(5):1069-1072
15. Cooper A, Brew S, de Lusignan S (2002) The effectiveness of blood tests in detecting secondary osteoporosis or mimicking conditions in postmenopausal women. Br J Gen Pract 52(477):311-313
16. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87(10):4431-4437